Johnson & Johnson Will Break Itself Up Into Two Companies
The 135-year-old company announced plans to divide itself into a [...]
Biden Chooses Robert Califf to Lead F.D.A., Despite Drug Industry Ties
Dr. Robert M. Califf, an academic and clinical trial researcher [...]
Antony Blinken Says ‘We Have Fallen Short’ on Global Vaccine Distribution
The Secretary of State called for rich countries, pharmaceutical companies [...]
Oklahoma Supreme Court Throws Out $465 Million Opioid Ruling Against J.&J.
The 5-1 decision is a setback for those who are [...]
Moderna and U.S. at Odds Over Vaccine Patent Rights
Moderna’s patent application names several employees as the sole inventors [...]
Democrats Choosing Less Risky Path on Drug Prices
Experts say recent compromises could create less harm in balancing [...]
House Passes $1 Trillion Infrastructure Bill, Putting Social Policy Bill on Hold
Progressives who had threatened to sink the measure agreed to [...]
Pfizer Says Its Antiviral Pill Is Highly Effective in Treating Covid
Pfizer’s is the second pill to show effectiveness against Covid-19, [...]
Elizabeth Holmes Trial Exposes Investors’ Lack of Due Diligence
Start-up investors have often suspended skepticism while chasing a hot [...]
U.K. Authorizes Merck’s Antiviral Pill for Covid-19
The authorization of Merck’s easy-to-use Covid treatment, molnupiravir, is a [...]